Transform
Corporate Training
Your Learning Journey
What's Happening in the Pharmaceutical Industry?
New approvals, pricing updates,
and SGK changes – all in one place!
Stay Ahead of the Trends – Click to Explore
Under the scope of health economics services, offerings include pharmacoeconomic modeling, cost-effectiveness analyses, and assessments of public budget impacts. Additionally, consultancy services are provided to healthcare-focused start-ups on business development and market entry strategies. These services contribute to optimizing health policies and budget management by enhancing the cost-effectiveness of companies operating in the pharmaceutical and healthcare sectors.
From the pre-approval phase to the stage of making the drug available for use, this includes communication with regulatory authorities, preparation of necessary dossiers, submission of applications, and post-launch monitoring activities.
It ensures the determination of drug prices in accordance with the rules set by the Ministry of Health and monitors these prices in line with regulations. By providing services such as securing appropriate pricing and regularly tracking necessary adjustments, it helps clients effectively manage the drug pricing process.
It aims to forecast market potential for drugs and related diseases. These research efforts help pharmaceutical companies gain insights into target audiences and market opportunities, enabling them to make strategic decisions.
The service includes developing strategies to enable companies in the healthcare and pharmaceutical sectors to effectively communicate with their target audiences. This offering covers a range of activities, including information campaigns for patients and healthcare professionals, health education programs, and marketing communication initiatives.
D I G I P H A R M A
C O N S U L T I N G
Discover our executive team
Ahmet Kemal Kardan, CEO
Chief Executive Officer
Ali Köprülü, CMO
CMO
Av. Betay Özay
Legal Advisor
Atila Kardan, CTO
CTO